The ureteral stent market is anticipated to rise to USD 385.9 Million in 2022 and likely to reach USD 616.8 Million by 2032 with a CAGR of 4.4% from 2022 to 2032.
Demand for ureteral stents is rising as they are made up of fine plastic tubes which are thin and flexibly used to restore urine flow through blocked ureters due to various disorders which are increasing the ureteral stent market growth during the forecast period from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Ureteral Stent Market Value (2022) | USD 385.9 Million |
| Ureteral Stent Market Anticipated Forecast Value (2032) | USD 616.8 Million |
| Ureteral Stent Market Projected Growth Rate (2022 to 2032) | 4.4% |
The adoption of ureteral stent is rising as they are placed in ureters through a surgical procedure commonly known as ureteral stenting. One end of the device is placed in the urinary bladder while the other end remains in the kidney.
The ends may be coiled to prevent dislocation of the device. The stent is most often left temporarily till the blockage is removed. Therefore, it is likely to rise the ureteral stent market share in recent years.
Innovative interface platforms available in the market for stent case management and patient safety have been useful for both physicians and patients are rising the ureteral stent market demand analysis during the forecast period from 2022 to 2032.
Epidemiological data reveals that the prevalence of the stone disease is increasing which indicates that demand for ureteral stent would increase in future. The end-user industries such as Hospitals and Gastrointestinal surgery clinics are the leading industry which is growing the ureteral stent market trends in the market.
These industries are upsurging the demand for the devices which directly increase the sales of ureteral stent during the forecast period.
Explore FMI!
Book a free demo
The key contributor to the ureteral stent market size includes an increasing number of urological procedures owing to a sedentary lifestyle and expanding elder population base during the forecast period from 2022 to 2032.
Poor dietary habits and fluid intake, increasing obesity levels and a rising caseload of metabolic disorders may fuel the rate of ureteral stent market growth. Advancements in stent composition materials leading to minimizing patient discomfort, mesh stent design and construction can give additional favour in the ureteral stent statistics.
The availability of innovative smartphone applications has grown the ureteral stent market trends for stent case management and patient safety, which are useful for both physicians and patients.
The complex procedure of stent placement, lack of skilled surgeons, complications after removal of the stent and discomfort in living with a ureteral stent with side effects such as increased frequency of passing urine and urgency to pass urine are the major factors that may restraint for ureteral stent market growth.
North America is expected to dominate the ureteral stent market size due to the increased number of urological surgeries, the presence of key global players in the region and continuous centre of attention towards research and development projects.
North America acquired 33.0% of the share in the ureteral stent market share as per the ureteral stent market survey during the forecast period from 2022 to 2032.
Europe is projected to register the second position in the ureteral stent market growth owing to favourable patient demographics and developing healthcare infrastructure in the region. The Europe region acquires 29.0% of the share in the ureteral stent market share during the forecast period from 2022 to 2032.
The lack of urologists and insufficient proper training is expected to boost the ureteral stents market demand analysis in the Europe region.
In order to enhance market penetration, startups in the ureteral stent market are also attempting to produce technologically innovative items. This is expected to increase revenue for the organization in the coming years.
The startups in ureteral stent market are adopting several technologies to improve the devices in certain ways are drug-eluting stents, localized stenting and drug-coated stent to boost the future sales of ureteral stent in the coming forecast period.
Adopting a better way in the ureteral stent device is to focus on the comfortable of the device without any infection which is likely to influence the ureteral stent market trends & forecast in coming years.
The key players in the global ureteral stent market include Boston Scientific, Bard Medical, Cook Medical, Coloplast, B.Barun, Applied Medical, Allium Medical, Teleflex, Urotech, Urovision, Opti-Med, Goharshafa, Surgimedik, Mednova, Taewoong Medical and Prosurg, and others.
The key players are the prominent players which are anticipated to influence the ureteral stent market future trends during the forecast period from 2022 to 2032. They are pointing toward the new advanced methodology to boost the adoption of ureteral stent in the coming forecast period from 2022 to 2032.
Recent Developments in Ureteral Stent Market are:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 4.4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
Composition Material, Type, Application, End User, Region |
| Regions Covered |
North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled |
Boston Scientific Corporation; B. Braun Melsungen AG; Cook Medical; BD; Coloplast Ltd.; Medline Industries; Merit Medical Systems, Inc.; Olympus Corporation; Teleflex Incorporated |
| Customization | Available Upon Request |
The ureteral stent market is likely to advance at a CAGR of 4.4% through 2032.
The North American region holds a ureteral stent market share of 33.0% by 2032.
The ureteral stent market is anticipated to expect USD 385.9 Million in 2022.
The ureteral stent market is expected to account for USD 616.8 Million by 2032.
Ureteral Stent Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
